Please wait...
About This Project
70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Understanding the perspective of women who use the Billings Ovulation Method
Fertility awareness-based methods (FABM) are a group of family planning methods that teach women how to...
How does involvement in kink, fetish or BDSM impact a person's health?
Kink-involved people engage in atypical erotic activities such as bondage, rough sex, and fetish activities...
110%
funded
$3,000
goal
3
lab notes
Mathematical model to reduce maternal and infant mortality in Southeast Asia
Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...
